These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38468422)

  • 21. A Prospective Study to Evaluate Efficacy Using the Nuro Percutaneous Tibial Neuromodulation System in Drug-Naïve Patients With Overactive Bladder Syndrome.
    Kobashi K; Nitti V; Margolis E; Sand P; Siegel S; Khandwala S; Newman D; MacDiarmid SA; Kan F; Michaud E
    Urology; 2019 Sep; 131():77-82. PubMed ID: 31199966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Home-based transcutaneous tibial nerve stimulation for overactive bladder syndrome: a randomized, controlled study.
    Cava R; Orlin Y
    Int Urol Nephrol; 2022 Aug; 54(8):1825-1835. PubMed ID: 35622269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is the addition of vaginal electrical stimulation to transcutaneous tibial nerve electrical stimulation more effective for overactive bladder treatment? A randomized controlled trial.
    Bacchi Ambrosano Giarreta F; Milhem Haddad J; Souza de Carvalho Fusco HC; Chada Baracat E; Casarotto RA; Alves Gonçalves Ferreira E
    Actas Urol Esp (Engl Ed); 2021; 45(1):64-72. PubMed ID: 32660872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment for overactive bladder: A meta-analysis of transcutaneous tibial nerve stimulation versus percutaneous tibial nerve stimulation.
    Yang DY; Zhao LN; Qiu MX
    Medicine (Baltimore); 2021 May; 100(20):e25941. PubMed ID: 34011072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Multicenter Study Evaluating the FREquency of Use and Efficacy of a Novel Closed-Loop Wearable Tibial Neuromodulation System for Overactive Bladder and Urgency Urinary Incontinence (FREEOAB).
    Goudelocke C; Sobol J; Poulos D; Enemchukwu E; Zaslau S; Dhir R
    Urology; 2024 Jan; 183():63-69. PubMed ID: 37944596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trial.
    Chapple C; Schneider T; Haab F; Sun F; Whelan L; Scholfield D; Dragon E; Mangan E
    BJU Int; 2014 Sep; 114(3):418-26. PubMed ID: 24552358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcutaneous tibial nerve stimulation versus parasacral stimulation in the treatment of overactive bladder in elderly people: a triple-blinded randomized controlled trial.
    Jacomo RH; Alves AT; Lucio A; Garcia PA; Lorena DCR; de Sousa JB
    Clinics (Sao Paulo); 2020; 75():e1477. PubMed ID: 31939564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of percutaneous and transcutaneous posterior tibial nerve stimulation on idiopathic overactive bladder and interstitial cystitis/painful bladder syndrome: A systematic review and meta-analysis.
    Ghavidel-Sardsahra A; Ghojazadeh M; Rahnama'I MS; Naseri A; Yazdandoost S; Khezerloo T; Seyedi-Sahebari S; Hosseinifard H; Vahed N; Mostafaei H; Salehi-Pourmehr H; Hajebrahimi S
    Neurourol Urodyn; 2022 Feb; 41(2):539-551. PubMed ID: 35032328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcutaneous tibial nerve stimulation in the treatment of lower urinary tract symptoms and its impact on health-related quality of life in patients with Parkinson disease: a randomized controlled trial.
    Perissinotto MC; DʼAncona CA; Lucio A; Campos RM; Abreu A
    J Wound Ostomy Continence Nurs; 2015; 42(1):94-9. PubMed ID: 25549314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative Efficacy of Neuromodulation Technologies for Overactive Bladder in Adults: A Network Meta-Analysis of Randomized Controlled Trials.
    Huang J; Fan Y; Zhao K; Yang C; Zhao Z; Chen Y; Yang J; Wang T; Qu Y
    Neuromodulation; 2023 Dec; 26(8):1535-1548. PubMed ID: 35989159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different electrode positioning for transcutaneous electrical nerve stimulation in the treatment of urgency in women: a study protocol for a randomized controlled clinical trial.
    Padilha JF; Avila MA; Seidel EJ; Driusso P
    Trials; 2020 Feb; 21(1):166. PubMed ID: 32046754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of solifenacin on diary-recorded and patient-reported urgency in patients with severe overactive bladder (OAB) symptoms.
    Serels SR; Toglia MR; Forero-Schwanhaeuser S; He W
    Curr Med Res Opin; 2010 Oct; 26(10):2277-85. PubMed ID: 20707767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes following percutaneous tibial nerve stimulation (PTNS) treatment for neurogenic and idiopathic overactive bladder.
    Tudor KI; Seth JH; Liechti MD; Ochulor J; Gonzales G; Haslam C; Fox Z; Pakzad M; Panicker JN
    Clin Auton Res; 2020 Feb; 30(1):61-67. PubMed ID: 30074101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Transcutaneous Tibial Nerve Stimulation in Women Refractory to and Never Used Pharmacological Agents for Idiopathic Overactive Bladder.
    Yildiz N; Celtek MA
    Int Urogynecol J; 2024 Mar; 35(3):571-578. PubMed ID: 38206337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcutaneous posterior tibial nerve electrostimulation with low dose trospium chloride: Could it be used as a second line treatment of overactive bladder in females.
    Abulseoud A; Moussa A; Abdelfattah G; Ibrahim I; Saba E; Hassouna M
    Neurourol Urodyn; 2018 Feb; 37(2):842-848. PubMed ID: 28792105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of transcutaneous tibial nerve stimulation at two different thresholds for overactive bladder symptoms in older women: a randomized controlled clinical trial.
    Teixeira Alve A; Azevedo Garcia P; Henriques Jácomo R; Batista de Sousa J; Borges Gullo Ramos Pereira L; Barbaresco Gomide Mateus L; Gomes de Oliveira Karnikoskwi M
    Maturitas; 2020 May; 135():40-46. PubMed ID: 32252963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study).
    Herschorn S; Chapple CR; Abrams P; Arlandis S; Mitcheson D; Lee KS; Ridder A; Stoelzel M; Paireddy A; van Maanen R; Robinson D
    BJU Int; 2017 Oct; 120(4):562-575. PubMed ID: 28418102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parasacral versus tibial transcutaneous electrical stimulation to treat urinary urgency in adult women: Randomized controlled clinical trial.
    Falcão Padilha J; Arias Avila M; Driusso P
    Eur J Obstet Gynecol Reprod Biol; 2021 Dec; 267():167-173. PubMed ID: 34773880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of an implant technique and early experience using a novel implantable pulse generator with a quadripolar electrode array at the tibial nerve for refractory overactive bladder.
    Sirls LT; Schonhoff A; Waldvogel A; Peters KM
    Neurourol Urodyn; 2023 Feb; 42(2):427-435. PubMed ID: 36573835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A New Implanted Posterior Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome: 3-Month Results of a Novel Therapy at a Single Center.
    van Breda HMK; Martens FMJ; Tromp J; Heesakkers JPFA
    J Urol; 2017 Jul; 198(1):205-210. PubMed ID: 28189576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.